Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Icon Plc (NQ: ICLR ) 299.24 +4.00 (+1.35%) Streaming Delayed Price Updated: 2:00 PM EDT, Oct 18, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Press Releases about Icon Plc < Previous 1 2 3 Next > ICON plc Schedules Third Quarter 2024 Earnings Conference Call September 27, 2024 From ICON plc Via Business Wire ICON Survey Highlights Scale of Focus on Precision Therapies in Increasingly Complex Oncology Landscape September 12, 2024 From ICON plc Via Business Wire ICON plc to Present at the Baird 2024 Global Healthcare Conference September 03, 2024 From ICON plc Via Business Wire ICON Announces Appointment of New Chief Financial Officer August 14, 2024 From ICON plc Via Business Wire ICON Reports Second Quarter 2024 Results July 24, 2024 From ICON plc Via Business Wire ICON announces results of Annual General Meeting and changes to the Board of Directors July 24, 2024 From ICON plc Via Business Wire ICON Recognised for Leadership Position in Clinical Research Industry and as Socially Responsible Employer July 10, 2024 From ICON plc Via Business Wire ICON plc Schedules Second Quarter 2024 Earnings Conference Call July 01, 2024 From ICON plc Via Business Wire ICON plc to Present at the Jefferies Global Healthcare Conference June 04, 2024 From ICON plc Via Business Wire ICON Hosts Investor Day and Updates Full Year 2024 Financial Guidance May 30, 2024 From ICON plc Via Business Wire ICON plc to hold Investor Day Meeting on May 30, 2024 May 20, 2024 From ICON plc Via Business Wire ICON releases its ICON Cares 2023 Report May 09, 2024 From ICON plc Via Business Wire ICON Announces Pricing of USD 2 Billion Notes April 30, 2024 From ICON plc Via Business Wire ICON Reports First Quarter 2024 Results April 24, 2024 From ICON plc Via Business Wire ICON Announces CFO Transition April 03, 2024 From ICON plc Via Business Wire ICON plc Schedules First Quarter 2024 Earnings Conference Call March 25, 2024 From ICON plc Via Business Wire ICON plc to Present at Upcoming Investor Conferences February 26, 2024 From ICON plc Via Business Wire ICON Reports Fourth Quarter and Full Year 2023 Results February 21, 2024 From ICON plc Via Business Wire ICON plc Schedules Fourth Quarter and Full Year 2023 Earnings Conference Call January 30, 2024 From ICON plc Via Business Wire New ICON Survey Highlights Importance of Combination Therapies in Future Obesity Treatment January 24, 2024 From ICON plc Via Business Wire ICON Issues Financial Guidance for Full Year 2024 January 09, 2024 From ICON plc Via Business Wire Biotech companies to increase R&D spend but highlight complexity of clinical trials - ICON January 08, 2024 From ICON plc Via Business Wire ICON plc to Present at the 42nd Annual J.P. Morgan Healthcare Conference January 04, 2024 From ICON plc Via Business Wire ICON Wins Industry Accolades from TIME Magazine, Forbes and Financial Times in Second Half of 2023 December 18, 2023 From ICON plc Via Business Wire ICON Secures Upgraded Credit Rating from Moody’s Investors Service December 07, 2023 From ICON plc Via Business Wire ICON plc to Present at Upcoming Investor Conferences November 08, 2023 From ICON plc Via Business Wire ICON Reports Third Quarter 2023 Results October 25, 2023 From ICON plc Via Business Wire ICON Secures Upgraded Credit Rating from S&P Global Ratings October 12, 2023 From ICON plc Via Business Wire ICON plc Schedules Third Quarter 2023 Earnings Conference Call September 21, 2023 From ICON plc Via Business Wire ICON Releases Expanded End-to-end Clinical Trial Tokenisation Solution September 20, 2023 From ICON plc Via Business Wire < Previous 1 2 3 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.